Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia
| Condition | Alzheimer's Disease |
|---|---|
| Phase | N/A |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Status | Completed |
| Enrollment | 14 participants |
| Interventions | Active lighting intervention, Control lighting intervention |
| Start date | Jan 6, 2022 |
| Completion date | May 1, 2023 |
| Results posted | Jul 30, 2026 |
Summary
To test the effect of a tailored lighting intervention controlled by the Readings At Desk (RAD) controller on sleep and mood in Alzheimer's disease participants.
Sleep Disturbance Using the Pittsburgh Sleep Quality Index (PSQI)
| Active Lighting Intervention | 6.5 ± 4.3 Score on a scale |
|---|---|
| Control Lighting | 4 ± 2.3 Score on a scale |
| Active Lighting Intervention | 4.1 ± 2.3 Score on a scale |
| Control Lighting | 6 ± 3.3 Score on a scale |
Open in BENITIONS View on ClinicalTrials.gov
Other trials for this condition
- Brain Energy for Amyloid Transformation in Alzheimer's Disease Study — Wake Forest University Health Sciences
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss — Eli Lilly and Company
- Deprescribing in Patients Living With Dementia With Caregiver and Provider Nudges — Brigham and Women's Hospital
- Technology and Family Thriving Study — University of California, Santa Barbara
- Community-based Brain Health Program to Address Dementia Risk — Posit Science Corporation
- Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzhei — Georgetown University